-
1
-
-
33745777816
-
Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients
-
DOI 10.1210/jc.2005-2730
-
Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X & Bertherat J 2006 Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. Journal of Clinical Endocrinology and Metabolism 91 2650-2655. (doi:10.1210/jc.2005-2730) (Pubitemid 44024632)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.7
, pp. 2650-2655
-
-
Abiven, G.1
Coste, J.2
Groussin, L.3
Anract, P.4
Tissier, F.5
Legmann, P.6
Dousset, B.7
Bertagna, X.8
Bertherat, J.9
-
2
-
-
26944468635
-
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: A large prospective phase II trial
-
DOI 10.1677/erc.1.01025
-
Berruti A, Terzolo M, Sperone P, Pia A, Della Casa S, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F et al. 2005 Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocrine-Related Cancer 12 657-666. (doi:10.1677/erc.1.01025) (Pubitemid 41482999)
-
(2005)
Endocrine-Related Cancer
, vol.12
, Issue.3
, pp. 657-666
-
-
Berruti, A.1
Terzolo, M.2
Sperone, P.3
Pia, A.4
Della Casa, S.5
Gross, D.J.6
Carnaghi, C.7
Casali, P.8
Porpiglia, F.9
Mantero, F.10
Reimondo, G.11
Angeli, A.12
Dogliotti, L.13
-
3
-
-
84857943100
-
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
-
doi:10.1530/EJE-11-0918
-
BerrutiA, Sperone P, Ferrero A, GermanoA,ArditoA, Priola AM,De Francia S, Volante M, Daffara F, Generali D et al. 2011 Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. European Journal of Endocrinology 166 451-458. (doi:10.1530/EJE-11-0918)
-
(2011)
European Journal of Endocrinology
, vol.166
, pp. 451-458
-
-
Berruti, A.1
Sperone, P.2
Ferrero, A.3
Germano, A.4
Ardito, A.5
Priola, A.M.6
De Francia, S.7
Volante, M.8
Daffara, F.9
Generali, D.10
-
4
-
-
4444333522
-
Low toxicity and anticancer activity of a novel liposomal cisplatin (lipoplatin) in mouse xenografts
-
Boulikas T 2004 Low toxicity and anticancer activity of a novel liposomal cisplatin (lipoplatin) in mouse xenografts. Oncology Reports 12 3-12.
-
(2004)
Oncology Reports
, vol.12
, pp. 3-12
-
-
Boulikas, T.1
-
5
-
-
0030990935
-
Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-Related Kaposi's sarcoma
-
Coukell AJ & Spencer CM 1997 Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 53 520-538. (doi:10.2165/00003495-199753030-00011) (Pubitemid 27117367)
-
(1997)
Drugs
, vol.53
, Issue.3
, pp. 520-538
-
-
Coukell, A.J.1
Spencer, C.M.2
-
6
-
-
84155162799
-
Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer
-
doi:10.1097/SLA.0b013e3182402d21
-
DemeureMJ, Stephan E, Sinari S,Mount D, Gately S,Gonzales P, HostetterG, Komorowski R, Kiefer J, Grant CS et al. 2012 Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer. Annals of Surgery 255 140-146. (doi:10.1097/SLA. 0b013e3182402d21)
-
(2012)
Annals of Surgery
, vol.255
, pp. 140-146
-
-
Demeure, M.J.1
Stephan, E.2
Sinari, S.3
Mount, D.4
Gately, S.5
Gonzales, P.6
Hostetter, G.7
Komorowski, R.8
Kiefer, J.9
Grant, C.S.10
-
7
-
-
4444332837
-
Low renal toxicity of lipoplatin compared to cisplatin in animals
-
Devarajan P, Tarabishi R, Mishra J, Ma Q, Kourvetaris A, Vougiouka M & Boulikas T 2004 Low renal toxicity of lipoplatin compared to cisplatin in animals. Anticancer Research 24 2193-2200. (Pubitemid 39166294)
-
(2004)
Anticancer Research
, vol.24
, Issue.4
, pp. 2193-2200
-
-
Devarajan, P.1
Tarabishi, R.2
Mishra, J.3
Ma, Q.4
Kourvetaris, A.5
Vougiouka, M.6
Boulikas, T.7
-
8
-
-
0032758610
-
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors
-
Drummond DC, Meyer O, Hong K, Kirpotin DB & Papahadjopoulos D 1999 Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacological Reviews 51 691-743.
-
(1999)
Pharmacological Reviews
, vol.51
, pp. 691-743
-
-
Drummond, D.C.1
Meyer, O.2
Hong, K.3
Kirpotin, D.B.4
Papahadjopoulos, D.5
-
9
-
-
74049087050
-
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer
-
Eichhorn ME, Ischenko I, Luedemann S, Strieth S, Papyan A, Werner A, Bohnenkamp H, Guenzi E, Preissler G, Michaelis U et al. 2010 Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. International Journal of Cancer 126 1235-1245.
-
(2010)
International Journal of Cancer
, vol.126
, pp. 1235-1245
-
-
Eichhorn, M.E.1
Ischenko, I.2
Luedemann, S.3
Strieth, S.4
Papyan, A.5
Werner, A.6
Bohnenkamp, H.7
Guenzi, E.8
Preissler, G.9
Michaelis, U.10
-
10
-
-
0030447506
-
Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line
-
Fallo F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G, BoscaroM& Sonino N 1996 Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line. Endocrine Research 22 709-715. (Pubitemid 26424397)
-
(1996)
Endocrine Research
, vol.22
, Issue.4
, pp. 709-715
-
-
Fallo, F.1
Pilon, C.2
Barzon, L.3
Pistorello, M.4
Pagotto, U.5
Altavilla, G.6
Boscaro, M.7
Sonino, N.8
-
11
-
-
0031881541
-
Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line
-
DOI 10.1159/000007104
-
Fallo F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G, BoscaroM& Sonino N 1998 Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line. Chemotherapy 44 129-134. (doi:10.1159/000007104) (Pubitemid 28105426)
-
(1998)
Chemotherapy
, vol.44
, Issue.2
, pp. 129-134
-
-
Fallo, F.1
Pilon, C.2
Barzon, L.3
Pistorello, M.4
Pagotto, U.5
Altavilla, G.6
Boscaro, M.7
Sonino, N.8
-
12
-
-
84861888600
-
Combination chemotherapy in advanced adrenocortical carcinoma
-
doi:10.1056/NEJMoa1200966
-
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B et al. 2012 Combination chemotherapy in advanced adrenocortical carcinoma. New England Journal of Medicine 366 2189-2197. (doi:10.1056/NEJMoa1200966)
-
(2012)
New England Journal of Medicine
, vol.366
, pp. 2189-2197
-
-
Fassnacht, M.1
Terzolo, M.2
Allolio, B.3
Baudin, E.4
Haak, H.5
Berruti, A.6
Welin, S.7
Schade-Brittinger, C.8
Lacroix, A.9
Jarzab, B.10
-
13
-
-
0036875493
-
Liposomal drug carrier systems in cancer chemotherapy: Current status and future prospects
-
DOI 10.1080/1061186021000043061
-
Gabizon AA 2002 Liposomal drug carrier systems in cancer chemotherapy: current status and future prospects. Journal of Drug Targeting 10 535-538. (doi:10.1080/1061186021000043061) (Pubitemid 36124351)
-
(2002)
Journal of Drug Targeting
, vol.10
, Issue.7
, pp. 535-538
-
-
Gabizon, A.A.1
-
14
-
-
0037681850
-
Pharmacokinetics of pegylated liposomal doxorubicin: Review of animal and human studies
-
doi:10.2165/00003088-200342050-00002
-
Gabizon A, Shmeeda H & Barenholz Y 2003 Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clinical Pharmacokinetics 42 419-436. (doi:10.2165/00003088-200342050-00002)
-
(2003)
Clinical Pharmacokinetics
, vol.42
, pp. 419-436
-
-
Gabizon, A.1
Shmeeda, H.2
Barenholz, Y.3
-
15
-
-
84856279574
-
Pharmacological basis of pegylated liposomal doxorubicin: Impact on cancer therapy
-
doi:10.1016/j.ejps.2011.09.006
-
Gabizon A, Shmeeda H & Grenader T 2011 Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy. European Journal of Pharmaceutical Sciences 45 388-398. (doi:10.1016/j.ejps.2011.09.006)
-
(2011)
European Journal of Pharmaceutical Sciences
, vol.45
, pp. 388-398
-
-
Gabizon, A.1
Shmeeda, H.2
Grenader, T.3
-
16
-
-
33745458519
-
Albumin-bound paclitaxel: A next-generation taxane
-
DOI 10.1517/14656566.7.8.1041
-
Gradishar WJ 2006 Albumin-bound paclitaxel: a next-generation taxane. Expert Opinion on Pharmacotherapy 7 1041-1053. (doi:10.1517/14656566.7.8.1041) (Pubitemid 43949942)
-
(2006)
Expert Opinion on Pharmacotherapy
, vol.7
, Issue.8
, pp. 1041-1053
-
-
Gradishar, W.J.1
-
17
-
-
76149110071
-
Anti insulin-like growth factor i receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency
-
doi:10.1210/jc.2009-1980
-
Hantel C, Lewrick F, Schneider S, Zwermann O, Perren A, Reincke M, Suss R & Beuschlein F 2010 Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency. Journal of Clinical Endocrinology and Metabolism 95 943-952. (doi:10.1210/jc.2009-1980)
-
(2010)
Journal of Clinical Endocrinology and Metabolism
, vol.95
, pp. 943-952
-
-
Hantel, C.1
Lewrick, F.2
Schneider, S.3
Zwermann, O.4
Perren, A.5
Reincke, M.6
Suss, R.7
Beuschlein, F.8
-
18
-
-
84862063030
-
Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma
-
doi:10.1530/JOE-11-0427
-
Hantel C, Lewrick F, Reincke M, Suss R & Beuschlein F 2012 Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma. Journal of Endocrinology 213 155-161. (doi:10.1530/JOE-11-0427)
-
(2012)
Journal of Endocrinology
, vol.213
, pp. 155-161
-
-
Hantel, C.1
Lewrick, F.2
Reincke, M.3
Suss, R.4
Beuschlein, F.5
-
19
-
-
0036907725
-
Liposomally targeted cytotoxic drugs for the treatment of cancer
-
doi:10.1211/0022357002243
-
Harrington KJ, Syrigos KN & Vile RG 2002 Liposomally targeted cytotoxic drugs for the treatment of cancer. Journal of Pharmaceutics & Pharmacology 54 1573-1600. (doi:10.1211/0022357002243)
-
(2002)
Journal of Pharmaceutics & Pharmacology
, vol.54
, pp. 1573-1600
-
-
Harrington, K.J.1
Syrigos, K.N.2
Vile, R.G.3
-
21
-
-
34548482374
-
Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential
-
doi:10.2217/17435889.1.3.297
-
Immordino ML, Dosio F & Cattel L 2006 Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine 1 297-315. (doi:10.2217/17435889.1.3.297)
-
(2006)
International Journal of Nanomedicine
, vol.1
, pp. 297-315
-
-
Immordino, M.L.1
Dosio, F.2
Cattel, L.3
-
22
-
-
77954926892
-
Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study
-
doi:10.3892/ol-00000131
-
LeonardiV, PalmisanoV,PepeA,Usset A,ManuguerraG, SavioG,DeBellaMT, Laudani A, Alu M, Cusimano MP et al. 2010 Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: a phase II study. Oncology Letters 1 749-753. (doi:10.3892/ol-00000131)
-
(2010)
Oncology Letters
, vol.1
, pp. 749-753
-
-
Leonardi, V.1
Palmisano, V.2
Pepe, A.3
Usset, A.4
Manuguerra, G.5
Savio, G.6
De Bella, M.T.7
Laudani, A.8
Alu, M.9
Cusimano, M.P.10
-
23
-
-
34249810952
-
Adrenocortical cancer: Pathophysiology and clinical management
-
DOI 10.1677/erc.1.01130
-
Libe R, Fratticci A & Bertherat J 2007 Adrenocortical cancer: pathophysiology and clinical management. Endocrine-Related Cancer 14 13-28. (doi:10.1677/erc.1.01130) (Pubitemid 47521719)
-
(2007)
Endocrine-Related Cancer
, vol.14
, Issue.1
, pp. 13-28
-
-
Libe, R.1
Fratticci, A.2
Bertherat, J.3
-
24
-
-
66149129222
-
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer
-
Miele E, Spinelli GP, Miele E, Tomao F & Tomao S 2009 Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. International Journal of Nanomedicine 4 99-105.
-
(2009)
International Journal of Nanomedicine
, vol.4
, pp. 99-105
-
-
Miele, E.1
Spinelli, G.P.2
Miele, E.3
Tomao, F.4
Tomao, S.5
-
25
-
-
0029090720
-
Sequencedependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo
-
doi:10.1002/ijc.2910620518
-
Milross CG, Peters LJ, Hunter NR, Mason KA & Milas L 1995 Sequencedependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. International Journal of Cancer 62 599-604. (doi:10.1002/ijc.2910620518)
-
(1995)
International Journal of Cancer
, vol.62
, pp. 599-604
-
-
Milross, C.G.1
Peters, L.J.2
Hunter, N.R.3
Mason, K.A.4
Milas, L.5
-
26
-
-
77950461582
-
Phase II study of liposomal cisplatin (lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
-
doi:10.1016/j.lungcan.2009.06.017
-
Mylonakis N, Athanasiou A, Ziras N, Angel J, Rapti A, Lampaki S, Politis N, Karanikas C & Kosmas C 2009 Phase II study of liposomal cisplatin (lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer. Lung Cancer 68 240-247. (doi:10.1016/j.lungcan.2009.06.017)
-
(2009)
Lung Cancer
, vol.68
, pp. 240-247
-
-
Mylonakis, N.1
Athanasiou, A.2
Ziras, N.3
Angel, J.4
Rapti, A.5
Lampaki, S.6
Politis, N.7
Karanikas, C.8
Kosmas, C.9
-
27
-
-
36549050900
-
Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer
-
DOI 10.1097/CAD.0b013e3282f14a00, PII 0000181320080100000001
-
O'Brien ME 2008 Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer. Anti-Cancer Drugs 19 1-7. (doi:10.1097/CAD.0b013e3282f14a00) (Pubitemid 350190962)
-
(2008)
Anti-Cancer Drugs
, vol.19
, Issue.1
, pp. 1-7
-
-
O'Brien, M.E.R.1
-
28
-
-
0026352832
-
Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
-
Papahadjopoulos D, Allen TM, Gabizon A,MayhewE,Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C et al. 1991 Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. PNAS 88 11460-11464. (doi:10.1073/pnas.88.24.11460) (Pubitemid 21916061)
-
(1991)
Proceedings of the National Academy of Sciences of the United States of America
, vol.88
, Issue.24
, pp. 11460-11464
-
-
Papahadjopoulos, D.1
Allen, T.M.2
Gabizon, A.3
Mayhew, E.4
Matthay, K.5
Huang, S.K.6
Lee, K.-D.7
Woodle, M.C.8
Lasic, D.D.9
Redemann, C.10
Martin, F.J.11
-
29
-
-
0346343244
-
Current status of liposomal anthracycline therapy in metastatic breast cancer
-
doi:10.3816/CBC.2003.s.019
-
Rivera E 2003 Current status of liposomal anthracycline therapy in metastatic breast cancer. Clinical Breast Cancer 4 (Suppl 2) S76-S83. (doi:10.3816/CBC.2003.s.019)
-
(2003)
Clinical Breast Cancer
, vol.4
, Issue.SUPPL. 2
-
-
Rivera, E.1
-
30
-
-
0033745993
-
Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies
-
doi:10.1006/phrs.2000.0714
-
Sengupta S, Tyagi P, Velpandian T, Gupta YK & Gupta SK 2000 Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacological Research 42 459-464. (doi:10.1006/phrs.2000.0714)
-
(2000)
Pharmacological Research
, vol.42
, pp. 459-464
-
-
Sengupta, S.1
Tyagi, P.2
Velpandian, T.3
Gupta, Y.K.4
Gupta, S.K.5
-
31
-
-
0036402578
-
Polyethylene glycol-liposomal doxorubicin: A review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma
-
doi:10.2165/00003495-200262140-00012
-
SharpeM, Easthope SE, Keating GM& LambHM2002 Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs 62 2089-2126. (doi:10.2165/00003495-200262140-00012)
-
(2002)
Drugs
, vol.62
, pp. 2089-2126
-
-
Sharpe, M.1
Easthope, S.E.2
Keating, G.M.3
Lamb, H.M.4
-
32
-
-
70350307006
-
Pharmacokinetics and tissue distribution of liposomal etoposide in rats
-
doi:10.3109/10717540903223418
-
Sistla A, Smith DJ, Kobrinsky NL & Kumar K 2009 Pharmacokinetics and tissue distribution of liposomal etoposide in rats. Drug Delivery 16 423-429. (doi:10.3109/10717540903223418)
-
(2009)
Drug Delivery
, vol.16
, pp. 423-429
-
-
Sistla, A.1
Smith, D.J.2
Kobrinsky, N.L.3
Kumar, K.4
-
34
-
-
80054748670
-
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
-
doi:10.1007/s00280-011-1572-5
-
Stathopoulos GP, Antoniou D, Dimitroulis J, Stathopoulos J, Marosis K & Michalopoulou P 2011Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology 68 945-950. (doi:10.1007/s00280-011-1572-5)
-
(2011)
Cancer Chemotherapy and Pharmacology
, vol.68
, pp. 945-950
-
-
Stathopoulos, G.P.1
Antoniou, D.2
Dimitroulis, J.3
Stathopoulos, J.4
Marosis, K.5
Michalopoulou, P.6
-
35
-
-
51649088789
-
Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin
-
doi:10.1158/1078-0432.CCR-07-4738
-
Strieth S, Eichhorn ME, Werner A, Sauer B, Teifel M, Michaelis U, Berghaus A & Dellian M 2008 Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin. Clinical Cancer Research 14 4603-4611. (doi:10.1158/1078-0432.CCR-07-4738)
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 4603-4611
-
-
Strieth, S.1
Eichhorn, M.E.2
Werner, A.3
Sauer, B.4
Teifel, M.5
Michaelis, U.6
Berghaus, A.7
Dellian, M.8
-
36
-
-
34249999500
-
Adjuvant mitotane treatment for adrenocortical carcinoma
-
DOI 10.1056/NEJMoa063360
-
Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E et al. 2007 Adjuvant mitotane treatment for adrenocortical carcinoma. New England Journal of Medicine 356 2372-2380. (Pubitemid 46883771)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.23
, pp. 2372-2380
-
-
Terzolo, M.1
Angeli, A.2
Fassnacht, M.3
Daffara, F.4
Tauchmanova, L.5
Conton, P.A.6
Rossetto, R.7
Buci, L.8
Sperone, P.9
Grossrubatscher, E.10
Reimondo, G.11
Bollito, E.12
Papotti, M.13
Saeger, W.14
Hahner, S.15
Koschker, A.-C.16
Arvat, E.17
Ambrosi, B.18
Loli, P.19
Lombardi, G.20
Mannelli, M.21
Bruzzi, P.22
Mantero, F.23
Allolio, B.24
Dogliotti, L.25
Berruti, A.26
more..
|